06Jan 2023
The Promise of Liquid Biopsies: Extracellular Vesicle microRNAs Open the Door to Future Study in Lung Disease

The Promise of Liquid Biopsies: Extracellular Vesicle microRNAs Open the Door to Future Study in Lung Disease

Chronic lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease develop in concert with long-term exposure to inhaled particulate matter and other acute injuries. Chronic lung diseases worsen with increased exposure to air pollution, particulate matter and smoke. Therefore, developing biomarkers that reflect early changes in the lung in response to injury may be a viable approach to advancing our knowledge of lung disease development. Peripheral blood biomarkers such as proteins, mRNA, microRNAs (miRNA), and extracellular vesicles (EVs) have revolutionized translational studies in pulmonary diseases. There are fundamental biologic limitations to concluding circulating proteins or RNA signals (such as miRNAs) for distal organ-specific pathogenesis. However, EVs may offer important bridges over these gaps between the peripheral blood and distal organ injury, such as the lung.

  • #critical care

Like

Save

Share